Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 non » _ non (Expand Search), a non (Expand Search), i non (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 non » _ non (Expand Search), a non (Expand Search), i non (Expand Search)
-
121
-
122
-
123
<i>Ext1</i> mutant lungs exhibit a decrease in SHH-FGF10 signaling.
Published 2017“…<p>(A) qPCR analysis of key components of FGF signaling pathway in lungs from E14.5. …”
-
124
Participant characteristics (non-weighted).
Published 2024“…Multivariate logistic regression models were developed for community ambulation. Mean age was 68 (SE 0.5) years (45% female). In the final community ambulation model (n = 855), factors associated with being less likely to ‘walk outdoors sometimes or often’ included difficulty or being unable to walk 2–3 blocks (decreased endurance) vs. no difficulty. …”
-
125
-
126
-
127
-
128
-
129
-
130
-
131
The decrease or inhibition of Hsp90 induced REST degradation.
Published 2019“…<p>(A) Effect of Hsp90α ASO on cell viability. Differentiated SH-SY5Y cells were transfected with different concentrations of Hsp90α ASO. …”
-
132
-
133
-
134
-
135
-
136
-
137
The MMP was decreased by incubation with CytoD or LatB.
Published 2014“…An MMP collapse was detected as a decrease in the percentage of cells with high red fluorescence intensity. …”
-
138
-
139
The MMP was decreased by incubation with CytoD or LatB.
Published 2014“…An MMP collapse was detected as a decrease in the percentage of cells with high red fluorescence intensity. …”
-
140
The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of non-caloric saccharin solution.
Published 2013“…<p>Ezlopitant (5 and 10 mg/kg) significantly decreased consumption of the non-caloric 0.2% saccharin solution compared to vehicle. …”